4.2 Article

Advanced diffusion imaging sequences could aid assessing patients with focal cortical dysplasia and epilepsy

Journal

EPILEPSY RESEARCH
Volume 108, Issue 2, Pages 336-339

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.eplepsyres.2013.11.004

Keywords

Diffusion imaging; Focal cortical dysplasia; Epilepsy surgery; NODDI; Neurite density

Funding

  1. Medical Research Council [G0802012]
  2. Engineering and Physical Sciences Research Council [EP/E007748]
  3. National Institute for Health Research University College London Hospitals Biomedical Research Centre
  4. EPSRC [EP/G007748/1] Funding Source: UKRI
  5. MRC [G0802012] Funding Source: UKRI
  6. Engineering and Physical Sciences Research Council [EP/G007748/1] Funding Source: researchfish
  7. Medical Research Council [G0802012] Funding Source: researchfish
  8. National Institute for Health Research [NF-SI-0509-10161] Funding Source: researchfish

Ask authors/readers for more resources

Malformations of cortical development (MCD), particularly focal cortical dysplasia (FCD), are a common cause of refractory epilepsy but are often invisible on structural imaging. NODDI (neurite orientation dispersion and density imaging) is an advanced diffusion imaging technique that provides additional information on tissue microstructure, including intracellular Volume fraction (ICVF), a marker of neurite density. We applied this technique in 5 patients with suspected dysplasia to show that the additional parameters are compatible with the underlying disrupted tissue microstructure and could assist in the identification of the affected area. The consistent finding was reduced ICVF in the area of dysplasia. In one patient, an area of reduced ICVF and increased fibre dispersion was identified that was not originally seen on the structural imaging. The focal reduction in ICVF on imaging is compatible with previous iontophoretic data in surgical specimens, was more conspicuous than on other clinical or diffusion images (supported by an increased contrast-to-noise ratio) and more localised than on previous DTI studies. NODDI may therefore assist the clinical identification and localisation of FCD in patients with epilepsy. Future studies will assess this technique in a larger cohort including MRI negative patients. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available